Harrison, D.C. : Practical guidelines for the use of lidocaine, prevention and treatment of cardiac arrhythmias. JAMA, 233: 1202, 1975.
2.
Lie, K.I., Wellens, H.J., Van Capelle, F.J., et al.: Lidocaine in the prevention of primary ventricular fibrillation. A double-blind randomized study of 212 consecutive patients. N. Engl. J. Med., 291: 1324, 1974.
3.
Pitt, A., Lipp, H., Anderson, S.T.: Lignocaine given prophylactically to patients with acute myocardial infarction . Lancet, 1: 612, 1971.
4.
Koch-Weser, J., Klein, S.W., Foo-Canto, L.L., et al.: Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction. N. Engl. J. Med. , 281: 1253, 1969.
5.
Nicholls, D.P. , Haybyrne, T., Barnes, P.C.: Intravenous and oral disopyramide after myocardial infarction. Lancet, 2: 936, 1980.
6.
Romhilt, D.W. , Bloomfield, S.S., Chou, T.-C., et al.: Unreliability of conventional electrocardiographic monitoring for arrhythmia detection in coronary care units. Am. J. Cardiol., 31: 457, 1973.
7.
De Soyza, N., Meacham, D., Murphy, M.L., et al.: Evaluation of warning arrhythmias before paroxysmal ventricular tachycardia during acute myocardial infarction in man. Circulation , 60: 814, 1979.
Thomson, P.D. , Melmon, K.L., Richardson, J.A., et al.: Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans. Ann. Intern. Med., 78: 499, 1973.
10.
Le Lorier, J., Grenon, P., Latour, Y., et al.: Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction. Ann. Intern. Med., 87: 700, 1977.
11.
Pfeifer, H.J. , Greenblatt, D.J., Koch-Weser, J.: Clinical use and toxicity of intravenous lidocaine. A report from the Boston Collaborative Drug Surveillance Program . Am. Heart J., 92: 168, 1976.
12.
Waxman, H.L. , Myerburg, R.J., Appel, R., et al.: Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter. Ann. Intern. Med., 94: 1, 1981.
13.
Antman, E.M. , Stone, P.H., Muller, J.E., et al.: Calcium channel blocking agents in the treatment of cardiovascular disorders: Part 1. Basic and clinical electrophysiologic effects. Ann. Intern. Med., 93: 875, 1980.
14.
Rinkenberger, R.L., Prystowsky, E.N., Heger, J.J., et al.: Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias . Circulation, 62: 996, 1980.
15.
Sung, R.J., Elser, B., McAllister, R.G., Jr.: Intravenous verapamil for termination of re-entrant supraventricular tachycardias. Ann. Intern. Med., 93: 682, 1980.
16.
Hagemeijer, F.: Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction. Circulation, 57: 751, 1978.
17.
Vincenzi, M. , Morlino, T., Allegri, P., et al.: Changes in cardiovascular function induced by verapamil in healthy subjects and in patients with ischemic heart disease. Clin. Cardiol., 4: 15, 1981.
18.
Klein, H.O. , Lang, R., Di Segni, E., et al.: Verapamil-digoxin interaction. N. Engl. J. Med., 303: 160, 1980.
19.
Solberg, L.E. , Nissen, R.G., Vlietstra, R.E., et al.: Prinzmetal's variant angina—response to verapamil. Mayo Clin. Proc., 53: 256, 1978.
20.
Kastor, J.A. , Horowitz, L.N., Harken, A.H., et al.: Clinical electrophysiology of ventricular tachycardia. N. Engl. J. Med., 304: 1004, 1981 .
21.
Ruskin, J.N. , DiMarco, J.P., Garan, H.: Out-of-hospital cardiac arrest: Electrophysiologic observations and selection of long-term antiarrhythmic therapy. N. Engl. J. Med., 303: 607, 1980.
22.
Lown, B.: Sudden cardiac death: The major challenge confronting contemporary cardiology . Am. J. Cardiol., 43: 313, 1979.
23.
Kinney, E.L. , Field, E.H., Salmon, M.P., et al.: Cardiac arrhythmias associated with disopyramide. N. Engl. J. Med., 302: 1146, 1980 .
24.
Warnowicz, M.A., Denes, P.: Chronic ventricular arrhythmias: Comparative drug effectiveness and toxicity. Prog. Cardiovasc. Dis., 23: 225, 1980.
25.
Koch-Weser, J.: Drug therapy. Bretylium. N Engl. J. Med., 300: 473, 1979.
26.
Zipes, D.P. , Elharrar, V., Gilmour, R.F., Jr., et al.: Studies with aprindine. Am. Heart J., 100: 1055, 1980.
27.
Marcus, F.I. , Fontaine, G.H., Frank, R., et al.: Clinical pharmacology and therapeutic applications of the antiarrhythmic agent, amiodarone. Am. Heart J., 101: 480, 1981.
